225 related articles for article (PubMed ID: 30728353)
1. Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation.
Li Z; Czechowicz A; Scheck A; Rossi DJ; Murphy PM
Nat Commun; 2019 Feb; 10(1):616. PubMed ID: 30728353
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment of allogeneic bone marrow recipients with the CXCR4 antagonist AMD3100 transiently enhances hematopoietic chimerism without promoting donor-specific skin allograft tolerance.
Li Z; Xu X; Weiss ID; Jacobson O; Murphy PM
Transpl Immunol; 2015 Oct; 33(2):125-9. PubMed ID: 26209354
[TBL] [Abstract][Full Text] [Related]
3. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
[TBL] [Abstract][Full Text] [Related]
4. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
[TBL] [Abstract][Full Text] [Related]
6. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
Duran-Struuck R; Sondermeijer HP; Bühler L; Alonso-Guallart P; Zitsman J; Kato Y; Wu A; McMurchy AN; Woodland D; Griesemer A; Martinez M; Boskovic S; Kawai T; Cosimi AB; Yang YG; Hu Z; Wuu CS; Slate A; Mapara M; Baker S; Tokarz R; D'Agati V; Hammer S; Pereira M; Lipkin WI; Wekerle T; Levings M; Sykes M
Transplantation; 2017 Feb; 101(2):274-283. PubMed ID: 27846155
[TBL] [Abstract][Full Text] [Related]
7. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
[TBL] [Abstract][Full Text] [Related]
8. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
9. The Macrophage-depleting Agent Clodronate Promotes Durable Hematopoietic Chimerism and Donor-specific Skin Allograft Tolerance in Mice.
Li Z; Xu X; Feng X; Murphy PM
Sci Rep; 2016 Feb; 6():22143. PubMed ID: 26917238
[TBL] [Abstract][Full Text] [Related]
10. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
11. The intragraft vascularized bone marrow component plays a critical role in tolerance induction after reconstructive transplantation.
Lin CH; Anggelia MR; Cheng HY; Wang AYL; Chuang WY; Lin CH; Lee WPA; Wei FC; Brandacher G
Cell Mol Immunol; 2021 Feb; 18(2):363-373. PubMed ID: 31754236
[TBL] [Abstract][Full Text] [Related]
12. Infusion of Lin- bone marrow cells results in multilineage macrochimerism and skin allograft tolerance in minimally conditioned recipient mice.
Anam K; Amare MF; Zins SR; Davis TA
Transpl Immunol; 2010 Oct; 24(1):69-75. PubMed ID: 20950686
[TBL] [Abstract][Full Text] [Related]
13. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
[TBL] [Abstract][Full Text] [Related]
14. Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness.
Inverardi L; Linetsky E; Pileggi A; Molano RD; Serafini A; Paganelli G; Ricordi C
Transplantation; 2004 Mar; 77(5):647-55. PubMed ID: 15021823
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
19. Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation.
Czechowicz A; Palchaudhuri R; Scheck A; Hu Y; Hoggatt J; Saez B; Pang WW; Mansour MK; Tate TA; Chan YY; Walck E; Wernig G; Shizuru JA; Winau F; Scadden DT; Rossi DJ
Nat Commun; 2019 Feb; 10(1):617. PubMed ID: 30728354
[TBL] [Abstract][Full Text] [Related]
20. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
Johnstone BH; Messner F; Brandacher G; Woods EJ
Front Immunol; 2021; 12():622604. PubMed ID: 33732244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
